Intelligent Bio Solutions (NASDAQ:INBS) Stock Price Down 4.5% – What’s Next?

Intelligent Bio Solutions Inc. (NASDAQ:INBS) shares dropped 4.5% during mid-day trading on Monday . The stock traded as low as $1.47 and last traded at $1.50. Approximately 61,203 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 1,586,529 shares. The stock had previously closed at $1.57.

Intelligent Bio Solutions Price Performance

The stock has a market capitalization of $4.55 million, a price-to-earnings ratio of -0.04 and a beta of 4.70. The firm’s fifty day moving average is $1.57 and its 200-day moving average is $1.92.

Institutional Trading of Intelligent Bio Solutions

A hedge fund recently bought a new stake in Intelligent Bio Solutions stock. Virtu Financial LLC purchased a new stake in Intelligent Bio Solutions Inc. (NASDAQ:INBS) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,537 shares of the company’s stock, valued at approximately $53,000. Virtu Financial LLC owned approximately 0.40% of Intelligent Bio Solutions at the end of the most recent reporting period. Institutional investors and hedge funds own 32.97% of the company’s stock.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.